Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2016-2023: Trends, Key Players, Documents and Figures
May 11, 2023 05:18 ET
|
Research and Markets
Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2016-2023" report has been added to ResearchAndMarkets.com's offering.The Global...
Precision Cancer Therapeutics Market Research Report 2022: Analysis of Abecma, Breyanzi, Carvykti, Kymriah, Tecartus, Yescarta
December 22, 2022 05:43 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Precision Cancer Therapeutics, 2022" report has been added to ResearchAndMarkets.com's offering. The analyst has watched the cancer treatment market...
Global Cancer Monoclonal Antibody Partnering Deal Terms and Agreements 2015-2022: Latest Agreements in Monoclonal Antibodies, Murine mAb, Chimeric mAb, Humanized mAb, Human aAb
June 14, 2022 04:33 ET
|
Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2015-2022" report has been added to ResearchAndMarkets.com's offering. The Cancer...